ABSTRACT
Introduction Rheumatic heart disease (RHD) is an important cause of acquired heart disease in children and adolescents globally. Clinical trials on RHD treatment with traditional Chinese medicine (TCM) are gradually increasing in China. However, because clinical trials are heterogeneous and report outcomes selectively, similar studies cannot be merged and compared, complicating assessing the effectiveness and safety of TCM, diminishes the value of clinical trials, and results in a waste of research resources. Therefore, there is an urgent need to develop a core outcome set of traditional Chinese medicine for rheumatic heart disease (COS-TCM-RHD). This study will report the protocol development process for COS-TCM-RHD.
Methods and analysis A multidisciplinary Steering Committee will lead the development of this protocol through four stages (1). Establishing a comprehensive and systematic outcomes checklist through a systematic review of previously published research, retrieval of clinical trial registration centers, patient’s semi-structured interviews, and clinician’s questionnaire surveys; (2). Screen stakeholder groups from various fields to participate in the Delphi survey; (3). Two rounds of e-Delphi surveys will be conducted to determine the outcomes of various concerned stakeholder groups; (4). Hold a face-to-face consensus meeting to develop the COS-TCM-RHD.
Ethics and dissemination Ethical approval has been granted by the Tianjin university of Traditional Chinese Medicine Ethics Committee. The findings will be published in peer-reviewed journals and the website of Chinese Clinical Trials for Core Outcome Set.
Trial registration This study protocol has been prospectively registered with the Core Outcome Measures in Effectiveness Trials (COMET):
Strengths and limitations of this study
▪ This protocol is the first core outcomes set registered on the Core Outcome Measures in Effectiveness Trials (COMET) website for the treatment of rheumatic heart disease by Traditional Chinese medicine.
▪ This study is guided by the Core Outcome Set-STAndards for Development and Core Outcome Set-Standardized Protocol Items, with recommendations of the COMET.
▪ A multidisciplinary Steering Committee will supervise this research, and stakeholders from different fields including clinicians, patients, methodologists, and COS developers will be engaged.
▪ Systematic reviews, qualitative research (patient’s semi-structured interviews and clinician’s questionnaire surveys), Delphi surveys, and consensus meetings will be used for core outcome set development.
▪ Traditional Chinese medicine is mainly used in China. Thus, the geographical distribution of stakeholders will be a limitation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
http://www.comet-initiative.org/Studies/Details/1743
Funding Statement
This work was funded by the Special Support Plan for Talent Development of Tianjin-Young Top Talent Project (No.201504)/Tianjin Graduate Scientific Research Innovation Project (No.2021YJSB296/No.YJSKC-20211014)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committee of the Tianjin University of Traditional Chinese Medicine gave ethical approval for this work (TJUTCM-EC20210008).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Figure 1 revised
Data Availability
All data produced in the present study are available upon reasonable request to the author
Abbreviations
- RHD
- Rheumatic heart disease
- RF
- Rheumatic fever
- WM
- Western medicine
- TCM
- Traditional Chinese Medicine
- RCT
- Randomized controlled trials
- COS
- Core Outcome Set
- COMET
- Core Outcome Measures in Effectiveness Trials
- COS-TCM-RHD
- Core outcome set of traditional Chinese medicine for rheumatic heart disease
- CHICOS
- Chinese Clinical Trials COS Research Centre
- TJUTCM
- Tianjin University of Traditional Chinese Medicine
- COS-STAR
- Core Outcome Set- STAndards for Reporting
- COS-STAD
- Core Outcome Set- STAndards for Development
- COS-STAP
- Core Outcome Set- Standardized Protocol Items
- GRADE
- Grading of Recommendations Assessment, Development, and Evaluation
- mNGT
- Modified Nominal Group Technique
